Health Bulletin 19/October/2022

Published On 2022-10-19 11:58 GMT   |   Update On 2022-12-07 10:56 GMT

Here are the top health news for the day:59 drug samples including Cadila Pharma Aciloc 150 fail to qualify CDSCO testIn its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 59 medicine batches for failing to qualify a random drug sample test for the month of September, 2022.This came in line with the list of drugs,...

Login or Register to read the full article

Here are the top health news for the day:


59 drug samples including Cadila Pharma Aciloc 150 fail to qualify CDSCO test

In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 59 medicine batches for failing to qualify a random drug sample test for the month of September, 2022.

This came in line with the list of drugs, medical devices and cosmetics declared as Not of Standard Quality/Spurious/Adulterated/Misbranded for the Month of September, 2022.

These drug samples which are declared not of standard quality include Paracetamol Tablets IP 650 mg, Ascorbic Acid Tablets IP 500 mg manufactured by ANG Lifesciences India, Montelukast Sodium and Levocetirizine Dihydrochloride Tablets IP (Viznil) manufactured by Tirupati Medicare Limited, Atorvastatin Tablets IP 20 mg manufactured by Galpha Laboratories, Azithromycin Tablets IP 500mg AZUSTAN-500 Tablets manufactured by Mediwell Biotech and others.

For more details, check out the link given below:

59 Drug Samples Including Cadila Pharma Aciloc 150 Fail To Qualify CDSCO Test


Chemical hair straighteners may cause uterine cancer: study

Women who used chemical hair straightening products were at higher risk for uterine cancer compared to women who did not report using these products, according to a new study from the National Institutes of Health. The researchers found no associations with uterine cancer for other hair products that the women reported using, including hair dyes, bleach, highlights, or perms.

The study data includes 33,497 U.S. women ages 35-74 participating in the Sister Study, a study led by the National Institute of Environmental Health Sciences (NIEHS), part of NIH, that seeks to identify risk factors for breast cancer and other health conditions. The women were followed for almost 11 years and during that time 378 uterine cancer cases were diagnosed.

The researchers found that women who reported frequent use of hair straightening products, defined as more than four times in the previous year, were more than twice as likely to go on to develop uterine cancer compared to those who did not use the products.

Reference:

Che-Jung Chang, Katie M. O'Brien, Alexander P. Keil, Symielle A. Gaston, Chandra L. Jackson, Dale P. Sandler, Alexandra J. White. Use of Straighteners and Other Hair Products and Incident Uterine Cancer. Journal of the National Cancer Institute DOI: https://doi.org/10.1093/jnci/djac165 (2022).


Tamil Nadu Medical Council to eliminate all quacks in 3 years

Acting on the National Medical Commission's direction for eliminating quackery, the State Medical Council in Tamil Nadu has set up a 'Quackery Eradication Wing' to deal with the complaints in this regard.

Already Tamil Nadu Medical Council (TNMC) has received altogether 60 complaints against quacks across State within two months, reports The Hindu. Among these already 10 cases have been verified and the Council is prepared to file cases against them.

The information in this regard was shared by the president of State Medical Council, Dr K Senthil while addressing the media on Saturday at Government Rajaji Hospital. He further mentioned that the TNMC wing aims to eliminate all the quacks from Tamil Nadu and Puducherry within two to three years.

For more details, check out the link given below:

Tamil Nadu Medical Council To Eliminate All Quacks In 3 Years

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News